Development and Validation of Fenofibrate in Bulk and Tablets using UV-Spectroscopy: An Anti-Hypercholesterolemic Agent
DOI:
https://doi.org/10.22270/ajprd.v12i2.1373Abstract
The spectrophotometry provides versatile techniques for analyse drug in multi component pharmaceutical formulation in presence of various interferences. Simple, accurate, sensitive, precise and rapid UV-Spectrophotometric methods have been developed for the estimation of fenofibrate in bulk and tablet dosage form formulation. To determine the absorption maximum, the drug fenofibrate were scanned in wavelength range of 200-400nm in spectra measurement mode using the double beam UV-Spectrophotometer, 290 nm was selected as a sampling wavelength in DMF as solvent. Beer’s limit was obeyed in the range of 2-10 µg/ml for fenofibrate. The correlation coefficient found to be satisfactory. Validation parameters such as its accuracy, linearity, precision, limit of detection (LOD), and limit of quantitation (LOQ) was studied for proposed method according to the ICH guidelines. Results of all parameters were found to be satisfactory. The proposed method can be used effectively for routine analysis and estimation of fenofibrate in bulk and dosage form. The result demonstrated that the proposed method is accurate, precise and reproducible.
Downloads
References
El-Gindy A, Emara S, Mesbah MK, Hadad GM. Spectrophotometric and liquid chromatographic determination of fenofibrate and vinpocetine and their hydrolysis products. Farmaco. 2005;60:425-438.
Gaikwad PV, Sawant SD, Ghante MR, Munot NM. Three simple spectrometric methods for Fenofibrate in tablet form. J. Pharm. Research. 2011; 4(6):1741-1742.
Masnatta LD, Cuniberti LA, Rey RH, Werba JP. Determination of bezafibrate, ciprofibrate and fenofibric acid in human plasma by high-performance liquid chromatography. J Chrom Biomed Appl. 1996;687:437-442.
Kiran Rapolu, Raja Reddy Aleti, Rama Rao Tadikonda, Pravalika Patlolla, Narender Boggula. Method Development and Validation of Pregabalin in Bulk and Tablet Dosage Forms by UV Spectroscopy. International Journal of Advanced Chemistry Research. 2024; 6(1):53-57.
Jain N, Raghuwanshi R, Jain D. Development and Validation of RP-HPLC Method for Simultaneous Estimation of Atorvastatin Calcium and Fenofibrate in Tablet Dosage Forms. Indian J Pharm Sci. 2008;70(2):263-265.
M Akiful Haque, Boggula Narender, Cherukuri Sravanthi, Burugu Rakshanda Goud, Bukka Sony, Routhu Deepshika, Vasudha Bakshi. Development and Validation of Zero and First Order Spectrophotometric Method for Determination of Levomilnacipran in Bulk and Formulation. J. Pharm. Sci. & Res. 2020; 12(3):443-447.
Patel A, Macwana C, Parmar V, Patel S. Simultaneous determination of atorvastatin calcium, ezetimibe, and fenofibrate in a tablet formulation by HPLC. J AOAC Int. 2012; 95(2):419-23.
Thaidala Sriveni, 4Vanamala Naveen, Vemula Sai Rupa, Aeruva Renuka, Sunil Porika, M Akiful Haque, Vasudha Bakshi, Narender Boggula. Development and Validation of Dolutegravir in Bulk and Formulation: An Anti-Retroviral Drug Using UV-Spectroscopy. International Journal of Pharmaceutical Quality Assurance. 2021; 12(1):57-60.
Nakarani NV, Bhatt KK, Patel RD, Bhatt HS. Estimation of atorvastatin calcium and fenofibrate in tablets by derivative spectrophotometry and liquid chromatography. J AOAC Int. 2007; 90(3):700-705.
Banothu Bhadru, Narender Boggula, Tadikonda Rama Rao, Yelimeti Santhosha, Fathima Zainab. Method Development and Validation of Amlodipine Besylate in API and Pharmaceutical Dosage Form by UV Spectroscopy. International Journal of Research in Pharmacy and Pharmaceutical Sciences. 2023; 8(4):26-29.
Kadav AA, Vora DN. Stability indicating UPLC method for simultaneous determination of atorvastatin, fenofibrate and their degradation products in tablets. J Pharm Biomed Anal. 2008;48(1):120-126.
Published
How to Cite
Issue
Section
Copyright (c) 2024 Narender Boggula, Bhadru Banothu, Satya Sireesha Devu, Rama Rao Tadikonda, Kiran Rapolu
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
.